|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0007131,
umls-concept:C0017243,
umls-concept:C0022100,
umls-concept:C0079419,
umls-concept:C0812409,
umls-concept:C0919534,
umls-concept:C0936012,
umls-concept:C1511790,
umls-concept:C1514888,
umls-concept:C1521991,
umls-concept:C1704353
|
|
pubmed:issue |
5
|
|
pubmed:dateCreated |
2002-2-18
|
|
pubmed:abstractText |
Understanding molecular abnormalities could potentially lead to novel investigational approaches in the molecular epidemiology of lung cancer. These might include the identification of patients at high risk for primary NSCLC and the surveillance of patients with known NSCLC who are being treated using lung-sparing surgical strategies.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
0250-7005
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
21
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
3461-9
|
|
pubmed:dateRevised |
2006-10-24
|
|
pubmed:meshHeading |
pubmed-meshheading:11848510-Aged,
pubmed-meshheading:11848510-Bronchoalveolar Lavage Fluid,
pubmed-meshheading:11848510-Carcinoma, Non-Small-Cell Lung,
pubmed-meshheading:11848510-Electrophoresis,
pubmed-meshheading:11848510-Exons,
pubmed-meshheading:11848510-Female,
pubmed-meshheading:11848510-Genes, p53,
pubmed-meshheading:11848510-Genes, ras,
pubmed-meshheading:11848510-Glutathione Transferase,
pubmed-meshheading:11848510-Humans,
pubmed-meshheading:11848510-Immunohistochemistry,
pubmed-meshheading:11848510-Lung Neoplasms,
pubmed-meshheading:11848510-Male,
pubmed-meshheading:11848510-Middle Aged,
pubmed-meshheading:11848510-Mutation,
pubmed-meshheading:11848510-Tumor Suppressor Protein p53,
pubmed-meshheading:11848510-ras Proteins
|
|
pubmed:articleTitle |
GSTM1, P53 and K-ras molecular detection in resectable non-small cell lung cancer by denaturing gradient gel electrophoresis-bronchoalveolar lavage fluid analysis.
|
|
pubmed:affiliation |
European Institute of Oncology, Department of Medicine, Milano, Italy. giuseppe.curigliano@ieo.it
|
|
pubmed:publicationType |
Journal Article
|
